← Eichor
Study identifier: NCT07334418 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early General Anesthesia to Limit Experiences of Trauma During Cesarean Section-Pilot Study

Condition: Cesarean Section · Delivery; Trauma  ·  Sponsor: University of Pennsylvania

PhaseNA
Planned participants600
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Some patients who undergo cesarean section under spinal or epidural anesthesia can experience severe pain. Some patients who experience this kind of pain can experience symptoms of post-traumatic stress disorder (PTSD) after pregnancy. Currently, the two main options for treating this pain are general anesthesia (full medically induced unconsciousness) and using intravenous medications to reduce the pain and decrease anxiety. The EAGLET-CS Pilot is a pilot randomized trial that will test the feasibility of comparing the impact of these two options for preventing PTSD in a rigorous way for those patients who experience pain during their cesarean section after the baby is out.

This description comes directly from the study's public registry record.

Talk to the study team

Mark Neuman, MD  ·  215-746-7468  ·  eagletadmin@pennmedicine.upenn.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07334418